CircHIPK3

ncRNA information

ncRNA name

CircHIPK3

Specific or universal ncRNAs

Specific ncRNAs

Class

Circular RNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

miR-330-5p/RASSF1

Cancer information

Cancer name

Pancreatic Cancer

Cancer site

qRT-PCR,Western blot,Dual-luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Gemcitabine

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

CircHIPK3 Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Sponging miR-330-5p and Targets RASSF1

Tissue resource

cancer tissues and adjacent tissues of patients with PC

human prostate cancer cell lines PANC-1

human prostate cancer cell lines SW 1990

Experiment

None


Institute

Third Xiangya Hospital, Central South University

Cell Collection Committee of the Chinese Academy of Sciences

Country

China

China

Continent

Asia

Asia